BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1495 related articles for article (PubMed ID: 17397929)

  • 1. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antimicrobial activity and chemotherapeutic potential of inorganic derivatives of 2-(4'-thiazolyl)benzimidazole[thiabendazole]: X-ray crystal structures of [Cu(TBZH)2Cl]Cl.H2O.EtOH and TBZH2NO3 (TBZH=thiabendazole).
    Devereux M; McCann M; Shea DO; Kelly R; Egan D; Deegan C; Kavanagh K; McKee V; Finn G
    J Inorg Biochem; 2004 Jun; 98(6):1023-31. PubMed ID: 15149811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterisation and antimicrobial activity of copper(II) and manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH2) and 4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH2): X-ray crystal structures of [Cu(cdoa)(phen)2].8.8H(2)O and [Cu(4-Mecdoa)(phen)2].13H2O (phen=1,10-phenanthroline).
    Creaven BS; Egan DA; Karcz D; Kavanagh K; McCann M; Mahon M; Noble A; Thati B; Walsh M
    J Inorg Biochem; 2007 Aug; 101(8):1108-19. PubMed ID: 17555821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steric and hydrogen-bonding effects on the stability of copper complexes with small molecules.
    Wada A; Honda Y; Yamaguchi S; Nagatomo S; Kitagawa T; Jitsukawa K; Masuda H
    Inorg Chem; 2004 Sep; 43(18):5725-35. PubMed ID: 15332825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, crystal structure and biological activities of copper(II) complexes with chelating bidentate 2-substituted benzimidazole ligands.
    Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Grünert R; Gdaniec M; Tabin P
    J Inorg Biochem; 2006 Aug; 100(8):1389-98. PubMed ID: 16740312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and biological activities of two copper(II) complexes with diethylenetriamine and 2,2'-bipyridine or 1,10-phenanthroline as ligands.
    Patel RN; Singh N; Shukla KK; Niclós-Gutiérrez J; Castineiras A; Vaidyanathan VG; Nair BU
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Nov; 62(1-3):261-8. PubMed ID: 16257723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tri-, tetra-, and hexanuclear copper(II) phosphonates containing N-donor chelating ligands: synthesis, structure, magnetic properties, and nuclease activity.
    Chandrasekhar V; Senapati T; Sañudo EC; Clérac R
    Inorg Chem; 2009 Jul; 48(13):6192-204. PubMed ID: 19499939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1,3-Dimethylimidazolidine-2-selone-kappaSe)bis(1,10-phenanthroline-kappa2N,N')copper(II) bis(perchlorate) and bis(2,2'-bipyridyl-kappa2N,N')(imidazolidine-2-thione-kappaS)copper(II) bis(perchlorate).
    Blake AJ; Lippolis V; Pivetta T; Verani G
    Acta Crystallogr C; 2007 Aug; 63(Pt 8):m364-7. PubMed ID: 17675685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand effects on the structures and magnetic properties of tricyanomethanide-containing copper(II) complexes.
    Yuste C; Bentama A; Stiriba SE; Armentano D; De Munno G; Lloret F; Julve M
    Dalton Trans; 2007 Nov; (44):5190-200. PubMed ID: 17985027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]x2H2O, [Cu(phen)2(mal)]x2H2O and [Mn(phen)2(mal)]x2H2O (malH2=malonic acid) using human cancer cells.
    Deegan C; McCann M; Devereux M; Coyle B; Egan DA
    Cancer Lett; 2007 Mar; 247(2):224-33. PubMed ID: 16740357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dinuclear copper(II) complexes with {Cu2(mu-hydroxo)bis(mu-carboxylato)}+ cores and their reactions with sugar phosphate esters: A substrate binding model of fructose-1,6-bisphosphatase.
    Kato M; Tanase T; Mikuriya M
    Inorg Chem; 2006 Apr; 45(7):2925-41. PubMed ID: 16562948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N,N'-bis(N-hydroxyethylaminoethyl)oxamide.
    Jiang M; Li YT; Wu ZY; Liu ZQ; Yan CW
    J Inorg Biochem; 2009 May; 103(5):833-44. PubMed ID: 19324417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper(II) complexes of mono-anionic glutamate: anionic influence in the variations of molecular and supramolecular structures.
    Biswas C; Drew MG; Estrader M; Ghosh A
    Dalton Trans; 2009 Jul; (25):5015-22. PubMed ID: 19662294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
    Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
    J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper(I) complex O(2)-reactivity with a N(3)S thioether ligand: a copper-dioxygen adduct including sulfur ligation, ligand oxygenation, and comparisons with all nitrogen ligand analogues.
    Lee DH; Hatcher LQ; Vance MA; Sarangi R; Milligan AE; Sarjeant AA; Incarvito CD; Rheingold AL; Hodgson KO; Hedman B; Solomon EI; Karlin KD
    Inorg Chem; 2007 Jul; 46(15):6056-68. PubMed ID: 17580938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) complexes of 1,10-phenanthroline-derived ligands: studies on DNA binding properties and nuclease activity.
    Hirohama T; Kuranuki Y; Ebina E; Sugizaki T; Arii H; Chikira M; Tamil Selvi P; Palaniandavar M
    J Inorg Biochem; 2005 May; 99(5):1205-19. PubMed ID: 15833344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structure and biomimetic properties of Cu(II)-Cu(II) and Cu(II)-Zn(II) binuclear complexes: possible models for the chemistry of Cu-Zn superoxide dismutase.
    Patel RN; Singh N; Shukla KK; Gundla VL; Chauhan UK
    J Inorg Biochem; 2005 Feb; 99(2):651-63. PubMed ID: 15621300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular structure, bioavailability and bioactivity of [Cu(o-phen)2(cnge)](NO3)2.2H2O and [Cu(o-phen)(cnge)(H2O)(NO3)2] complexes.
    Ferrer EG; López Tévez LL; Baeza N; Correa MJ; Okulik N; Lezama L; Rojo T; Castellano EE; Piro OE; Williams PA
    J Inorg Biochem; 2007 May; 101(5):741-9. PubMed ID: 17331582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.
    Zheng YJ; Li XW; Li YT; Wu ZY; Yan CW
    J Photochem Photobiol B; 2012 Sep; 114():27-37. PubMed ID: 22704662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.